Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Brook Henry

    TitleAssistant Researcher
    SchoolUniversity of California, San Diego
    DepartmentPsychiatry
    Address200 W. Arbor Drive #8231
    CA San Diego 92103
    Phone619-543-4737
    vCardDownload vCard

      Collapse Research 
      Collapse Research Activities and Funding
      Effect of Cannabis Administration and Endocannabinoids on HIV Neuropathic Pain
      NIH/NIDA R01DA043430Feb 1, 2017 - Dec 31, 2020
      Role: Principal Investigator
      iSTEP: an mHealth Physical Activity and Diet Intervention for Persons with HIV
      NIH/NINR R01NR016912Aug 11, 2016 - May 31, 2021
      Role: Principal Investigator
      Endocannabinoids, Cannabis, and Neurocognitive Deficits in HIV
      NIH/NIDA R21DA036401Sep 3, 2014 - Aug 31, 2016
      Role: Principal Investigator
      Text Message Physical Activity Intervention to Treat Cognitive Deficits in HIV
      NIH/NIMH R21MH100968Sep 26, 2013 - Jul 31, 2015
      Role: Principal Investigator
      Inhibitory Deficits in Bipolar Disorder and Methamphetamine Dependence
      NIH/NIDA F32DA024524Feb 1, 2009 - Jan 31, 2011
      Role: Principal Investigator

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Minassian A, Henry B, Iudicello JE, Morgan EE, Letendre SL, Heaton RK, Perry W. Everyday functional ability in HIV and methamphetamine dependence. Drug Alcohol Depend. 2017 Jun 01; 175:60-66. PMID: 28399475.
        View in: PubMed
      2. Dufour CA, Marquine MJ, Fazeli PL, Umlauf A, Henry B, Zlatar Z, Montoya JL, Ellis RJ, Grant I, Moore DJ. A Longitudinal Analysis of the Impact of Physical Activity on Neurocognitive Functioning Among HIV-Infected Adults. AIDS Behav. 2016 Dec 19. PMID: 27990580.
        View in: PubMed
      3. Perry W, McIlwain M, Kloezeman K, Henry B, Minassian A. Diagnosis and characterization of mania: Quantifying increased energy and activity in the human behavioral pattern monitor. Psychiatry Res. 2016 06 30; 240:278-283. PMID: 27138818; PMCID: PMC4885760 [Available on 06/30/17].
      4. Henry B, Moore DJ. Preliminary Findings Describing Participant Experience With iSTEP, an mHealth Intervention to Increase Physical Activity and Improve Neurocognitive Function in People Living With HIV. J Assoc Nurses AIDS Care. 2016 Jul-Aug; 27(4):495-511. PMID: 26847379; PMCID: PMC4903897 [Available on 07/01/17].
      5. Minassian A, Young JW, Cope ZA, Henry B, Geyer MA, Perry W. Amphetamine increases activity but not exploration in humans and mice. Psychopharmacology (Berl). 2016 Jan; 233(2):225-33. PMID: 26449721; PMCID: PMC4703551 [Available on 01/01/17].
      6. Montoya JL, Wing D, Knight A, Moore DJ, Henry B. Development of an mHealth Intervention (iSTEP) to Promote Physical Activity among People Living with HIV. J Int Assoc Provid AIDS Care. 2015 Nov-Dec; 14(6):471-5. PMID: 26307212; PMCID: PMC4654667.
      7. van Enkhuizen J, Geyer MA, Minassian A, Perry W, Henry B, Young JW. Investigating the underlying mechanisms of aberrant behaviors in bipolar disorder from patients to models: Rodent and human studies. Neurosci Biobehav Rev. 2015 Nov; 58:4-18. PMID: 26297513; PMCID: PMC4684462 [Available on 11/01/16].
      8. Morgan EE, Doyle KL, Minassian A, Henry B, Perry W, Marcotte TD, Woods SP, Grant I. Elevated intraindividual variability in methamphetamine dependence is associated with poorer everyday functioning. Psychiatry Res. 2014 Dec 15; 220(1-2):527-34. PMID: 25081313; PMCID: PMC4252574.
      9. van Enkhuizen J, Henry B, Minassian A, Perry W, Milienne-Petiot M, Higa KK, Geyer MA, Young JW. Reduced dopamine transporter functioning induces high-reward risk-preference consistent with bipolar disorder. Neuropsychopharmacology. 2014 Dec; 39(13):3112-22. PMID: 25005251; PMCID: PMC4229584.
      10. Henry B, Geyer MA, Buell MR, Perry W, Young JW, Minassian A. Prepulse inhibition in HIV-1 gp120 transgenic mice after withdrawal from chronic methamphetamine. Behav Pharmacol. 2014 Feb; 25(1):12-22. PMID: 24281153; PMCID: PMC3926694.
      11. Dufour CA, Marquine MJ, Fazeli PL, Henry B, Ellis RJ, Grant I, Moore DJ. Physical exercise is associated with less neurocognitive impairment among HIV-infected adults. J Neurovirol. 2013 Oct; 19(5):410-7. PMID: 23934585; PMCID: PMC3795938.
      12. Henry B, Minassian A, Patt VM, Hua J, Young JW, Geyer MA, Perry W. Inhibitory deficits in euthymic bipolar disorder patients assessed in the human behavioral pattern monitor. J Affect Disord. 2013 Sep 25; 150(3):948-54. PMID: 23759280; PMCID: PMC3759601.
      13. Henry B, Minassian A, Perry W. Everyday functional ability across different phases of bipolar disorder. Psychiatry Res. 2013 Dec 30; 210(3):850-6. PMID: 23643188; PMCID: PMC3758417.
      14. Minassian A, Henry B, Woods SP, Vaida F, Grant I, Geyer MA, Perry W. Prepulse inhibition in HIV-associated neurocognitive disorders. J Int Neuropsychol Soc. 2013 Jul; 19(6):709-17. PMID: 23552464; PMCID: PMC3729041.
      15. Henry B, Geyer MA, Buell M, Perry W, Young JW, Minassian A. Behavioral effects of chronic methamphetamine treatment in HIV-1 gp120 transgenic mice. Behav Brain Res. 2013 Jan 01; 236(1):210-20. PMID: 22960458; PMCID: PMC3482284.
      16. Young JW, Henry B, Geyer MA. Predictive animal models of mania: hits, misses and future directions. Br J Pharmacol. 2011 Oct; 164(4):1263-84. PMID: 21410454; PMCID: PMC3229761.
      17. Minassian A, Henry B, Young JW, Masten V, Geyer MA, Perry W. Repeated assessment of exploration and novelty seeking in the human behavioral pattern monitor in bipolar disorder patients and healthy individuals. PLoS One. 2011; 6(8):e24185. PMID: 21912623; PMCID: PMC3166173.
      18. Henry B, Minassian A, van Rhenen M, Young JW, Geyer MA, Perry W. Effect of methamphetamine dependence on inhibitory deficits in a novel human open-field paradigm. Psychopharmacology (Berl). 2011 Jun; 215(4):697-707. PMID: 21279333; PMCID: PMC3102201.
      19. Henry B, Minassian A, Perry W. Effect of methamphetamine dependence on heart rate variability. Addict Biol. 2012 May; 17(3):648-58. PMID: 21182570; PMCID: PMC3117088.
      20. Perry W, Minassian A, Henry B, Kincaid M, Young JW, Geyer MA. Quantifying over-activity in bipolar and schizophrenia patients in a human open field paradigm. Psychiatry Res. 2010 Jun 30; 178(1):84-91. PMID: 20471103; PMCID: PMC2914139.
      21. Henry B, Minassian A, Young JW, Paulus MP, Geyer MA, Perry W. Cross-species assessments of motor and exploratory behavior related to bipolar disorder. Neurosci Biobehav Rev. 2010 Jul; 34(8):1296-306. PMID: 20398694; PMCID: PMC2900445.
      22. Henry B, Minassian A, Perry W. Effect of methamphetamine dependence on everyday functional ability. Addict Behav. 2010 Jun; 35(6):593-8. PMID: 20167435; PMCID: PMC2839012.
      23. Minassian A, Henry B, Geyer MA, Paulus MP, Young JW, Perry W. The quantitative assessment of motor activity in mania and schizophrenia. J Affect Disord. 2010 Jan; 120(1-3):200-6. PMID: 19435640; PMCID: PMC2795051.
      24. Perry W, Minassian A, Paulus MP, Young JW, Kincaid MJ, Ferguson EJ, Henry B, Zhuang X, Masten VL, Sharp RF, Geyer MA. A reverse-translational study of dysfunctional exploration in psychiatric disorders: from mice to men. Arch Gen Psychiatry. 2009 Oct; 66(10):1072-80. PMID: 19805697; PMCID: PMC2897252.
      25. Henry B, Minassian A, Paulus MP, Geyer MA, Perry W. Heart rate variability in bipolar mania and schizophrenia. J Psychiatr Res. 2010 Feb; 44(3):168-76. PMID: 19700172; PMCID: PMC2822123.